H1B Report
Side-by-side comparison

Health Research Inc., Roswell Park Cancer Inst Div vs INFOSYS LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity B
INFOSYS LIMITED
TXRank #1FEIN 58-1760235

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricHealth Research Inc., Roswell Park Cancer Inst DivINFOSYS LIMITED
Total filings62205,263
Certified %91.94%99.55%
Denied %4.84%0.21%
Withdrawn %0.00%0.20%
Cert-withdrawn %3.23%0.05%
Rank#1
Active yearsFY2010–FY2018FY2010–FY2026
Worksite stateNYTX

Outcomes — Health Research Inc., Roswell Park Cancer Inst Div

DOL case-status mix.

Outcome breakdown: Certified 91.9%, Cert-withdrawn 3.2%, Denied 4.8%
Outcome breakdown
OutcomeShare
Certified91.9%
Cert-withdrawn3.2%
Denied4.8%
Certified91.9%
Cert-withdrawn3.2%
Denied4.8%

Outcomes — INFOSYS LIMITED

DOL case-status mix.

Outcome breakdown: Certified 99.5%, Cert-withdrawn 0.0%, Withdrawn 0.2%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Health Research Inc., Roswell Park Cancer Inst Div
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103
FY20115
FY201210
FY201316
FY20145
FY201513
FY20163
FY20176
FY20181
FY20190
FY20200
FY20210
FY20220
FY20230
FY20240
FY20250
FY20260
INFOSYS LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,164
FY20111,681
FY201214,701
FY201332,232
FY201423,749
FY201533,214
FY201625,335
FY201720,571
FY201811,569
FY201921,420
FY202016
FY202129
FY202222
FY20232,269
FY20245,943
FY20255,790
FY20264,558

Top 5 occupations — Health Research Inc., Roswell Park Cancer Inst Div

Top 5 occupations — INFOSYS LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.